Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03956797 · ClinicalTrials.gov registry record · NA
Long Term Safety of Cooling Anesthesia for Intravitreal Injection
A NA study, sponsored by Recens Medical.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT03956797: Completed NA study, sponsored by Recens Medical.
NCT03956797 is a NA study that has completed, run by Recens Medical. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03956797, a NA study, has completed, sponsored by Recens Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
The purpose of this clinical study is to evaluate the long term safety and efficacy of cooling anesthesia application to the eye as anesthesia for intravitreal injection using a novel cooling anesthesia device.
Primary Outcome
Pain of intravitreal injection as measured by 10-point visual analog scale (VAS) (0 meaning no pain, 10 meaning the most severe pain).
Interventions
- DEVICE Recens Cooling Anesthesia Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2019-04-15 |
| Est. Completion | 2021-04-02 |
| Phase | NA |
What the finished NCT03956797 record still lists
NCT03956797 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 1 intervention - of which Recens Cooling Anesthesia Device is the first listed.
NCT03956797 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03956797 about?
NCT03956797 is a clinical study titled "Long Term Safety of Cooling Anesthesia for Intravitreal Injection". The purpose of this clinical study is to evaluate the long term safety and efficacy of cooling anesthesia application to the eye as anesthesia for intravitreal injection using a novel cooling anesthesia device.
What is the current status of trial NCT03956797?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2019-04-15. Estimated completion is 2021-04-02.
What interventions are being tested in trial NCT03956797?
The interventions under investigation include: Recens Cooling Anesthesia Device (DEVICE).
Who is sponsoring clinical trial NCT03956797?
This trial is sponsored by Recens Medical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03956797's enrollment target sits among peer trials
80 994th of 2000 higher than 941 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI